LeroyMGrahamMD
Pediatric Pulmonology • Miramar Beach, FLChronic Lung Disease of Prematurity and Infancy, Pediatric Asthma Pulmonology
Associate Clinical Professor of Pediatrics, Morehouse School of Medicine
Dr. Graham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
56 Vantage Pointe
Miramar Beach, FL 32550Phone+1 404-295-9181Fax+1 404-295-9181- Is this information wrong?
Summary
- Retired pediatric pulmonologist still active in areas of community based health education and screening to reduce persistent health disparities among minorities and other hight risk populations
Education & Training
University of ColoradoFellowship, Pediatric Pulmonology, 1986 - 1989
Fitzsimons Army Medical CenterResidency, Pediatrics, 1979 - 1982
Georgetown University School of MedicineClass of 1979
Certifications & Licensure
GA State Medical License 1993 - 2023
CO State Medical License 1981 - 2005- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Atlanta Magazine: Top Doctors Castle Connolly, 2007, 2009-2014
Publications & Presentations
PubMed
- 11 citationsA comparison of tiotropium, long-acting β2-agonists and leukotriene receptor antagonists on lung function and exacerbations in paediatric patients with asthma.Christian Vogelberg, Stanley Goldstein, LeRoy Graham, Alan Kaplan, Alberto de la Hoz, Eckard Hamelmann> ;Respiratory Research. 2020 Jan 13
- 4 citationsSafety of tiotropium Respimat® in black or African-American patients with symptomatic asthma.LeRoy Graham, Huib A. M. Kerstjens, Christian Vogelberg, Eckard Hamelmann, Stanley J. Szefler, Wendelgard Pisternick-Ruf, Michael Engel, Georges El Azzi, Anna Unseld, ...> ;Respiratory Medicine. 2019 Aug 1
- 43 citationsSafety and efficacy of tiotropium in children aged 1–5 years with persistent asthmatic symptoms: a randomised, double-blind, placebo-controlled trialElianne J.L.E. Vrijlandt, Georges El Azzi, Mark Vandewalker, Ned Rupp, Thomas Harper, LeRoy Graham, Stanley J. Szefler, Petra Moroni-Zentgraf, Ashish Sharma, Sebastian...> ;The Lancet. Respiratory Medicine. 2018 Feb 1
- Join now to see all
Press Mentions
Preliminary Data Suggest Disproportionate COVID-19 Burden in Hospitalized MinorityJune 17th, 2020
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
